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Implementation of an aortic screening program in
clinical practice: Implications for the Screen for
Abdominal Aortic Aneurysms Very Efficiently
(SAAAVE) ActScreening for the presence of an abdominal aortic an-
eurysm (AAA) in the asymptomatic patient has been high-
lighted through the educational efforts of the Society for
Vascular Surgery in passage of the Screen for Abdominal
Aortic Aneurysms Very Efficiently Act (SAAAVE Act). The
authors present a review of a mandated screening program
over one year through the regional Veterans Administra-
tion Service network in Northern California to identify
males 65 to 75 years of age who ever smoked at least 100
cigarettes during their lifetime. They present similar find-
ings to contemporary reports at a reasonable cost.
Screening programs must always consider the preva-
lence of the disease, the financial burden of performing the
test, and any morbidity incurred as a result of the screening
test. Additionally, the cost and mortality must be evaluated
both if the disease process is never identified as well as if the
disease is diagnosed and appropriately treated. With regard
to governmental insurance carriers, each Medicare screen-
ing benefit requires an Act of Congress such as those passed
for glaucoma, prostate cancer, colorectal cancer, and mam-
mography. Private carriers publish their own guidelines.
In 2004, the Society for Vascular Surgery, in coopera-
tion with industry and other professional organizations,
established the National Aneurysm Alliance. During this
same time period, the United States Preventive Services
Task Force recommended screening males between the
ages of 65 and 74 who had smoked at some point in their
lives. After an extensive lobbying effort, Congress finally
passed the SAAAVE Act in 2005 and President George
Bush signed the bill on February 8, 2006, for implementa-
tion in 2007.
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100 cigarettes or men and women with a family history of
AAA. Additionally, the patient’s primary physician is the
only provider appropriate to request the ultrasound scan
after completion of a “Welcome toMedicare” physical. The
Center for Medicare and Medicaid Services (CMS) created
the code G0389 to describe this screening and allotted
0.58 physician work relative value units (RVUs) and 3.08
total RVUs in 2009 when billing global. Follow-up ab-
dominal duplex scanning for surveillance of a known AAA
is still reported by CPT codes 93978 for a complete study
and 93979 for a limited evaluation. Several private carriers
have also created screening policies with regard to AAA.
For example, Cigna Healthcare published guidelines in
February 2007 that allow for one screening per lifetime in
any male between the age of 65 and 75 who has smoked at
some point in his life. Unlike the G-code used by CMS,
Cigna requires reporting such a duplex scan evaluation by
use of the non-vascular CPT codes: 76700 (complete),
76705 (limited), 76770 (complete), or 76775 (limited).
The original law took effect on January 1, 2007, and
less than 10,000 beneficiaries were screened for AAA that
year. Recently, the House of Representatives bill number
1213 was introduced as a bipartisan bill in an attempt to
unlink the AAA screening benefit from the Welcome to
Medicare physical exam and expand the one-time screening
to all 65 to 75 year old Medicare beneficiaries who are
at-risk for an AAA.
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